Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 10.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 746,595 shares of the company's stock after acquiring an additional 73,578 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.16% of GE HealthCare Technologies worth $60,116,000 as of its most recent SEC filing.
Other large investors have also recently made changes to their positions in the company. CoreFirst Bank & Trust purchased a new position in GE HealthCare Technologies in the fourth quarter worth about $25,000. Continuum Advisory LLC increased its holdings in GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after buying an additional 168 shares during the last quarter. Runnymede Capital Advisors Inc. bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at $28,000. Bank of Jackson Hole Trust bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at $32,000. Finally, Flagship Wealth Advisors LLC bought a new position in GE HealthCare Technologies in the 4th quarter worth $34,000. 82.06% of the stock is currently owned by institutional investors.
GE HealthCare Technologies Price Performance
Shares of GEHC stock traded up $0.70 on Monday, reaching $80.71. The company's stock had a trading volume of 4,151,176 shares, compared to its average volume of 2,938,521. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80. The company has a market capitalization of $36.91 billion, a price-to-earnings ratio of 18.64, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The stock's fifty day simple moving average is $86.70 and its 200-day simple moving average is $85.86. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.
GE HealthCare Technologies Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.23%.
Analysts Set New Price Targets
GEHC has been the subject of a number of analyst reports. Wells Fargo & Company upped their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their price objective for the stock from $95.00 to $103.00 in a research note on Wednesday, January 8th. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and lifted their target price for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. Finally, Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a report on Thursday, February 13th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $98.75.
Get Our Latest Report on GEHC
GE HealthCare Technologies Company Profile
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Read More
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
